Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in, and brand-name confidence. The famous $199 compounded era ended in March 2026 after the Novo Nordisk settlement; new patients now route to branded products only.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Hims & Hers | Eden | |
|---|---|---|
| Starts from | $199/mo (incl. medication) | $179/mo (incl. medication) |
| Lock-in | Month-to-month | 3-month minimum |
| Time to prescription | 1 day | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Hims & Hers | Eden | |
|---|---|---|
| Pricing transparency | 7/10 | 7/10 |
| Cancellation terms | 9/10 | 5/10 |
| Onboarding experience | 9/10 | 8/10 |
| Medication options | 7/10 | 5/10 |
| Member outcomes | 5/10 | 6/10 |
When to choose Hims & Hers
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable all-in monthly pricing.
When to choose Eden
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
FAQ
Is Hims & Hers cheaper than Eden?
Can I switch from Hims & Hers to Eden mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →